misterS makes an excellent point. The contract between PRR and the manufacturer is for the CVAC trials. The contract would be along the lines of "PRR promises to pay manufacturer $x for n vials of CVAC by such-and-such a date". DNDN could probably set up its own contract with the manufacturer for whatever it wants. If anyone has a step forward it's the manufacturer because they have probably just developed some clever packaging or dispensing technology that is relevant to both PRR and DNDN products (that could be a stock to watch...). Maybe the manufacturer is scaling up and PRR has first dibs on the product or, more likely, the manufacturer is going to use the CVAC trials to test out its new product. Just a thought.
PRR Price at posting:
19.5¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)